Company / Interest Expense
Bio-Techne Interest Expense History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$14.0M
FY2023
5-year range
$14.0M / $21.7M
FY2019-FY2023
Trend
-27.3%
vs FY2022
Sector context
#36 of 44
Health Care
What the data says
Bio-Techne's interest expense of $14M is lower than 82% of companies in the Health Care sector (FY2023). Interest Expense has fluctuated over the past 8 years, ranging from $2M in FY2016 to $22M in FY2021.
Based on SEC 10-K filings.
$14M in FY2023 with a 5-year CAGR of +6.5%.
Improved from $22M to $14M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -10.1%
- 5-Year CAGR
- +6.5%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 44This company $14.0M Sector average $316.9M
▼
-95.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +6.5%, indicating consistent growth.
- In FY2023, interest expense decreased 27.3% year-over-year.
- Ranks #36 out of 44 companies in the Health Care sector.
- Peak interest expense was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $14.0M | -27.3% |
| FY2022 | $19.2M | -11.6% |
| FY2021 | $21.7M | +13.1% |
| FY2020 | $19.2M | -11.6% |
| FY2019 | $21.7M | +113.0% |
| FY2018 | $10.2M | +38.4% |
| FY2017 | $7.4M | +321.1% |
| FY2016 | $1.7M | +13.2% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026